Randomized comparative clinical trial of diquafosol sodium and Rebamipide eye drops for VDT-related dry eye patients
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2017
Price : $35 *
At a glance
- Drugs Diquafosol (Primary) ; Rebamipide
- Indications Dry eyes
- Focus Therapeutic Use
- 05 Jan 2017 Status changed from active, no longer recruiting to completed.
- 04 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Jan 2016 Planned End Date changed from 31 Oct 2015 to 1 Jul 2016.